Dr. Shah has been with the Indianapolis-based company since 1994 when she joined as a senior statistician. She most recently served as global brand development leader for immunology.
In her new position, Dr. Shah will lead the worldwide IT efforts of the company.
“I want to create an environment in which IT enables and brings innovative solutions to business transformations across Lilly’s entire drug development value chain from discovery to commercial. I hope to do this by unleashing the potential of our employees and by building strong internal and external collaborations and thus play a critical role in bringing Lilly’s mission to life,” Dr. Shah said in a statement.
More articles on CIOs:
State CIOs seek final cyberattack response plan from federal officials
A third of CIOs say digital disruption is occurring right now within their organizations
Why the right CIO enables the ‘perfectly friction-less business’
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.